All Stories

  1. An Emerging Model for Cancer Development from a Tumor Microenvironment Perspective in Mice and Humans

    Article • January 2020, Springer Science + Business Media

    Ryuji Yamaguchi

  2. The resistant to immunotherapy is an inevitable step in tumor evolution.

    Article • Cancer Biology & Therapy, May 2018, Taylor & Francis

    Ryuji Yamaguchi

  3. Deconstructing Signaling Pathways in Cancer for Optimizing Cancer Combination Therapies

    Article • International Journal of Molecular Sciences, June 2017, MDPI AG

    Ryuji Yamaguchi

  4. Cholesterol on plasma of every cancer cell is a good target for cancer therapy

    Article • FEBS Letters, November 2015, Wiley

    Ryuji Yamaguchi

  5. Challenges in targeting cancer metabolism for cancer therapy

    Article • EMBO Reports, November 2012, EMBO

    Ryuji Yamaguchi

  6. Finding a Panacea among Combination Cancer Therapies

    Article • Cancer Research, November 2011, American Association for Cancer Research (AACR)

    Ryuji Yamaguchi

  7. Mcl-1 levels need not be lowered for cells to be sensitized for ABT-263/737-induced apoptosis

    Article • Cell Death and Disease, November 2011, Springer Science + Business Media

    Ryuji Yamaguchi

  8. Efficient Elimination of Cancer Cells by Deoxyglucose-ABT-263/737 Combination Therapy

    Article • PLOS One, September 2011, PLOS

    Ryuji Yamaguchi

  9. Dynamics of mitochondrial structure during apoptosis and the enigma of Opa1

    Article • Biochimica et Biophysica Acta (BBA) - Bioenergetics, August 2009, Elsevier

    Ryuji Yamaguchi

  10. Opa1-Mediated Cristae Opening Is Bax/Bak and BH3 Dependent, Required for Apoptosis, and Independent of Bak Oligomerization

    Article • Molecular Cell, August 2008, Elsevier

    Ryuji Yamaguchi

  11. Mitochondria frozen with trehalose retain a number of biological functions and preserve outer membrane integrity

    Article • Cell Death and Differentiation, September 2006, Springer Science + Business Media

    Ryuji Yamaguchi

  12. A Role for Ran-GTP and Crm1 in Blocking Re-Replication

    Article • Cell, April 2003, Elsevier

    Ryuji Yamaguchi

  13. Proteasome Inhibitors Alter the Orderly Progression of DNA Synthesis during S-Phase in HeLa Cells and Lead to Rereplication of DNA

    Article • Experimental Cell Research, November 2000, Elsevier

    Ryuji Yamaguchi

  14. The Human Homolog ofSaccharomyces cerevisiae CDC45

    Article • Journal of Biological Chemistry, July 1998, American Society for Biochemistry & Molecular Biology (ASBMB)

    Ryuji Yamaguchi

  15. Paxillin association in vitro with integrin cytoplasmic domain peptides

    Article • FEBS Letters, December 1996, Wiley

    Ryuji Yamaguchi

  16. Unphosphorylated and tyrosine-phosphorylated forms of a focal adhesion protein, paxillin, are substrates for calpain II in vitro: Implications for the possible involvement of calpain II in mitosis-specific degradation of paxillin

    Article • FEBS Letters, December 1994, Wiley

    Ryuji Yamaguchi